Ken Griffin Albemarle Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$72.85 - $100.09 $2.33 Million - $3.2 Million	-32,000 Reduced 1.4%	2,251,800 $213 Million
Q2 2024 Aug 14, 2024	SELL	$92.77 - $135.46 $42.7 Million - $62.3 Million	-460,100 Reduced 16.77%	2,283,800 $218 Million
Q1 2024 May 15, 2024	BUY	$108.73 - $146.89 $164 Million - $221 Million	1,505,100 Added 121.5%	2,743,900 $361 Million
Q4 2023 Feb 14, 2024	BUY	$113.26 - $170.8 $12.1 Million - $18.2 Million	106,500 Added 9.41%	1,238,800 $179 Million
Q3 2023 Nov 14, 2023	SELL	$162.63 - $243.44 $10.2 Million - $15.3 Million	-62,800 Reduced 5.25%	1,132,300 $193 Million
Q2 2023 Aug 14, 2023	BUY	$172.91 - $232.22 $3.46 Million - $4.64 Million	20,000 Added 1.7%	1,195,100 $267 Million
Q1 2023 May 15, 2023	BUY	$208.49 - $290.15 $93.4 Million - $130 Million	447,800 Added 61.57%	1,175,100 $260 Million
Q4 2022 Feb 14, 2023	BUY	$214.02 - $325.38 $30.6 Million - $46.5 Million	143,000 Added 24.47%	727,300 $158 Million
Q3 2022 Nov 14, 2022	BUY	$195.82 - $307.05 $19.5 Million - $30.6 Million	99,700 Added 20.57%	584,300 $155 Million

927

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.